NCT03250598View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 9, 2017

Primary Completion Date

October 2, 2017

Study Completion Date

October 9, 2017

Conditions
HealthyJapaneseNon-Asian
Interventions
DRUG

AG-348

50 mg single-dose

DRUG

AG-348

5 mg single-dose

DRUG

AG-348

200 mg single-dose

Trial Locations (1)

90630

West Coast Clinical Trial (WCCT) Global, Inc., Cypress

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY